Johnson & Johnson (NYSE:JNJ) announced that Q2 net income of $4.52B or $1.61 a share, as compared to $4.33B or $1.51 a share, previous year. Excluding after-tax intangible amortization costs and special items, adjusted net earnings were $4.8B and adjusted EPS were $1.71, for the quarter. On an operational basis, […]